Prognosis

Newsom in Isolation; North Carolina Cites ‘Danger’: Virus Update

WATCH: The efficacy of the Oxford-Astra vaccine fell short of the high bar set by Pfizer and Moderna, according to trial results.(Source: Bloomberg)

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Bloomberg News

November 22, 2020 at 11:19 PM UTC

Updated on

November 23, 2020 at 8:43 PM UTC

This article is for subscribers only.

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

A Covid-19 vaccine developed by the University of Oxford and AstraZeneca Plc prevented a majority of people from getting the disease but fell short of the bar set by Pfizer Inc. and Moderna Inc. The virus is forecast to claim another 30,000 American lives by mid-December.